Crispr Therapeutics (CRSP) News Mentions Statistics 2024

0 100%

1W 0% 1M 0% 3M 0%

Est. daily news mentions.

Similar companies

Company		News Mentions
	Amgen AMGN	0 0%
	Gilead Sciences GILD	2 0%
	Catalyst Pharmaceuticals CPRX	0 0%
	Inovio Pharmaceuticals INO	0 100%
	Anavex Life Sciences AVXL	0 0%

CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)

November 20

Venturi Wealth Management LLC Has $80,000 Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)

November 15

CRISPR Therapeutics AG (CRSP) Guggenheim Inaugural Healthcare Innovation Conference (Transcript)

November 14

CRISPR Therapeutics AG (NASDAQ:CRSP) Stake Reduced by Leavell Investment Management Inc.

November 11

CRISPR Therapeutics AG (NASDAQ:CRSP) Receives $74.94 Consensus Price Target from Analysts

November 10

Crispr Therapeutics Q3 Earnings: No Casgevy Revenue, But Plenty Of Optimism

November 10

Brookline Capital Management Forecasts CRSP FY2024 Earnings

November 9

CRISPR Therapeutics AG (NASDAQ:CRSP) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

November 6

Wall Street Analysts See a 62.75% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High?

November 5

CRSP's Q3 Loss Narrower Than Expected, Sales Miss Estimates

November 5

CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates

November 4

CRISPR Therapeutics AG (CRSP) Just Overtook the 20-Day Moving Average

November 3

CRISPR Therapeutics AG (CRSP) Recently Broke Out Above the 50-Day Moving Average

November 3

Month over Month

Est. daily news mentions.

Oct 2024	0	69.4%
Sep 2024	0	17.3%
Aug 2024	0	66.7%
Jul 2024	0	16.1%
Jun 2024	0

How often is Crispr Therapeutics mentioned in the news?

Crispr Therapeutics was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Crispr Therapeutics performing compared to its industry peers?

Crispr Therapeutics underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Crispr Therapeutics in the last month?

There has been no significant change in the number of news mentions for Crispr Therapeutics' compared to the last month.

Why is it important to track news mentions for Crispr Therapeutics?

By monitoring mentions in the news for Crispr Therapeutics, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Crispr Therapeutics, ultimately improving their investment strategies.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

Top Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact

Crispr Therapeutics (CRSP) - News Mentions